Drug Profile
Anti-interleukin-6 receptor monoclonal antibody - Biocad
Alternative Names: Anti IL-6R MAbLatest Information Update: 12 Mar 2021
Price :
$50
*
At a glance
- Originator Biocad
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 6 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 12 Mar 2021 Discontinued - Phase-II for Autoimmune disorders in Russia (Parenteral)
- 13 Apr 2018 Phase-II clinical trials in Autoimmune disorders in Russia (Parenteral) (Biocad pipeline, April 2018)
- 06 Mar 2018 Phase-I clinical trials in Autoimmune disorders in Russia (Parenteral) (Biocad pipeline, March 2018)